Bristol-Myers Squibb Co. (BMY) Misses Q4 EPS by 2c, Sales Fall Just Short

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.5 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• BMO starts chip stocks coverage: Here are its preferred picks